SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brad C. Dunlap who wrote (969)6/8/1997 2:02:00 PM
From: AARON DIDICH   of 1762
 
Brad:

You read correctly,here is the quote: "Feinberg predicts this drug will generate $100million in earnings in 1998, its first year on the
market. At a stock price of 22 1/8, IDEC is selling at four times
Feinberg's 1998 pretax earnings estimate."

What do you know of Oracle Partners? If IDEC only was to receive the
royalties and fees on $100M of sales, how much would that equate to as
a most conservative estimate of the above quote?

All aboaaarrrrdddddd!

Market opens at 0930 in case anyone forgot.

Aaron
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News